Login to Your Account



Novacta Gets $21M Backing for Antibiotics Development

By Nuala Moran


Wednesday, July 8, 2009
LONDON - Private equity fund Celtic Pharma Holdings II LP is taking control of Novacta Biosystems Ltd., committing to invest up to £13 million (US$21 million) in the antibiotics specialist. The money will be invested in tranches against an agreed upon schedule of milestones in three programs. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription